Skip to content
Aperlena
Free alerts

Spain - Pharmaceutical products - Framework supply agreement (CONTR 2026 0000292688)

Original España - Productos farmacéuticos - Contrato Acuerdo Marco de Suministro (CONTR 2026 0000292688)

Closed Contract notice

Key facts

Closed
Buyer
Servicio Andaluz de Salud. Complejo Hospitalario Torrecárdenas.
Where
Spain Andalucía
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
574167-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Deadline open for 34 days
  3. Awarded pending

Summary

Machine-generated summary

The Andalusian Health Service (Servicio Andaluz de Salud) in Spain is concluding a framework agreement with several companies under Article 16.3.a) of the Spanish Public Sector Contracts Law (LCSP), setting conditions for successive-tranche, unit-price supply of selected medicines to health centres in Andalusia. The medicines include abacavir, abemaciclib, aflibercept, alpha-1-antitrypsin, amoxicillin, apremilast, aripiprazole, avelumab, BCG (dried live culture), carfilzomib, ceftazidime, ceftriaxone, colistin, daratumumab, dasatinib and denosumab. The total estimated budget is 256,886,101.58 euros including VAT. This is a multi-company framework agreement procedure.

Description

ACUERDO MARCO CON VARIAS EMPRESAS, POR EL QUE SE FIJAN LAS CONDICIONES PARA EL SUMINISTRO DE TRACTO SUCESIVO Y PRECIO UNITARIO AL AMPARO DEL ART. 16.3. a) DE LA LCSP, DE MEDICAMENTOS SELECCIONADOS (ABACAVIR, ABEMACICLIB, AFLIBERCEPT, ALFA-1-ANTITRIPSINA, AMOXICILINA, APREMILAST, ARIPIPRAZOL, AVELUMAB, BCG (CULTIVO VIVO DESECADO), CARFILZOMIB, CEFTAZIDIMA, CEFTRIAXONA, COLISTINA, DARATUMUMAB, DASATINIB Y, DENOSUMAB), DESTINADOS A LOS CENTROS SANITARIOS DEL SERVICIO ANDALUZ DE SALUD. Presupuesto total: 256.886.101,58 € (IVA incluido). Lote 1 AM SUM

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

1 open tender right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,341,044
9,705 open across Europe right now
Buyer track record on Aperlena
90 notices tracked · 57 awarded
€304,257,054 in awarded contracts

Never miss a tender like this

909 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language